4.7.3 SCFAs may alleviate GERD symptoms by supporting immune homeostasis and reducing inflammation SCFA, especially butyrate, can alter the secretion of pro-inflammatory mediators (e.g., interferon (IFN) - (IL-1, IL-2, IL-6, IL-8, tumor necrosis factor (TNF) - ) by a possible mechanism through inhibition of NF-B in intestinal epithelial cells (96, 97)
The formula is expert-developed and backed by science
(1966) Haemolysis of blood following exposure to an Austrialian manufactured plastic tubing sterilized by means of ethylene oxide gas
[1] That is the archetype of translational success: a defined molecule, a defined indication, a measurable endpoint (visceral fat), and confirmatory randomized trials
doi: 10.1016/j.ijantimicag.2012.05.009 211 SinghVKAlmpaniMMauraDKitaoTFerrariLFontanaSet al
A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers